Economic disparity drives Covid vaccine distribution inequality

8 December 2020 (Last Updated December 8th, 2020 07:57)

8 December

Gregory Daco, an economist, shared an article on the greatest vaccine effort in history, with the UK leading the pack to clear the first shot from Pfizer and BioNTech. The US is also making similar efforts and has succeeded in developing the Moderna vaccine candidate, mRNA-1273, which revealed 94.5% efficacy in its early stage data.

Experts believe that by the end of the year millions will be inoculated, and billions across the globe. The article explains how nine potential vaccines are being tracked around the globe, on the basis of national procurement deals to patients being administered doses. According to the data collected, 7.85 million doses of Covid-19 vaccines have already been allotted.

Economists believe that this maybe enough to meet the vaccine requirements of at least half the world, if administered evenly. However, it is a fact that the economically richer countries have placed higher bets on these vaccines with extensive supply agreements, while the need for ultra-cold storage requirements make it even more difficult for tropical countries and emerging markets to bag the vaccine deals, the article detailed.

Meanwhile, countries like Russia and China are carving their own path and are most likely to depend on domestically produced vaccines such as the Sputnik V and Sinopharm-made vaccine. The two countries authorised these vaccines in July and expect their entire populations to be vaccinated.

Read more